Organizational Chart International Technology Transfer General Information Career Opportunities


Spacer

 
Licensing & Royalties
spacer
 

Licensing Opportunities

Technology Abstracts

Print This Abstract Apply Questions ?
Regulation of ATG7 Beclin 1 Program of Autophagic Cell Death by Caspase-8

Description of Invention:
The invention discloses the role of autophagy in regulation cell death. Further it teaches a method of inducing autophagic cell death by administering a caspase inhibitor. The invention also discloses that autophagic cell death can be induced by caspase-8 inhibition and requires the genes ATG7 and Beclin 1.

Inventors:
Michael Lenardo and Yu Li (NIAID) et al.

Patent Status:
DHHS Reference No. E-318-2004/0-US-01 -- U.S. Provisional Application No. 60/556,857 filed 30 May 2004
Licensing Status: In addition to licensing, the technology is available for further development through collaborative research opportunities with the inventors.


Portfolios:
Internal Medicine

Internal Medicine-Therapeutics-Anti-Inflammatory (including Autoimmune)
Internal Medicine-Therapeutics


For Additional Information Please Contact:
Mojdeh Bahar J.D.
NIH Office of Technology Transfer
6011 Executive Blvd, Suite 325
Rockville, MD 20852-3804
Phone: (301)435-2950
Email: baharm@mail.nih.gov
Fax: (301) 402-0220


Web Ref: 1089

Updated: 4/05

 

 
 
Spacer